Benzodiazepines and benzodiazepine-like drugs: Safety label updates in Canada
In plain language
This advisory involves benzodiazepines and benzodiazepine-like prescription drugs sold in Canada. Health Canada is updating the safety labels for these drugs. The updates provide more prominent information about severe and potentially life-threatening risks.
What to do
- Consult with your doctor or pharmacist if you have questions or concerns.
- Use these medications exactly as prescribed by your healthcare professional.
- Store medications securely and out of reach of children.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Risk of problematic use, substance use disorder, severe withdrawal, and harm when taken with opioids.
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Risk of problematic use, substance use disorder, severe withdrawal, and harm when taken with opioids.
What should consumers do?
Consult with your doctor or pharmacist if you have questions or concerns. Use these medications exactly as prescribed by your healthcare professional. Store medications securely and out of reach of children.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Risk of problematic use, substance use disorder, severe withdrawal, and harm when taken with opioids.
When was this product recalled?
This product was recalled on October 30, 2020.